Anthony Atala to Cost-Benefit Analysis
This is a "connection" page, showing publications Anthony Atala has written about Cost-Benefit Analysis.
Connection Strength
0.628
-
Rao MS, Atala A. Developing Induced Pluripotent Stem Cell-Based Therapy for the Masses. Stem Cells Transl Med. 2016 Feb; 5(2):129-31.
Score: 0.528
-
Mhashilkar A, Atala A. Editorial: effective bio-economic approaches for stem cell therapy and regenerative medicine. Curr Stem Cell Res Ther. 2012 Jan; 7(1):1.
Score: 0.100